Modulating speed-accuracy strategies in major depression.

J Psychiatr Res

Department of Experimental & Clinical Medicine (DISM), Inter-University Center for Behavioural Neurosciences (ICBN), University of Udine, Udine, Italy; Department of Psychiatry & Behavioral Sciences, University of Texas Medical School at Houston, TX, USA; IRCCS 'E. Medea', Scientific Institute, Udine, Italy.

Published: January 2015

Background: Depression is associated with deficits in cognitive flexibility. The role of general slowing in modulating more specific cognitive deficits is however unclear.

Aim: We assessed how depression affects the capacity to strategically adapt behavior between harsh and prudent response modalities and how general and specific processes may contribute to performance deficits.

Methods: Patients suffering from major depression and age- and education-matched healthy controls were asked to randomly stress either speed or accuracy during perceptual decision-making.

Results: Diffusion models showed that patients with depression kept using a less conservative strategy after a trial with speed vs. accuracy instructions. Additionally, the depression group showed a slower rate of evidence accumulation as indicated by a generally lower drift rate.

Conclusions: These data demonstrate that less efficient strategic regulation of behavior in depression is due not only to general slowing, but also to more specific deficits, such as a rigid dependence on past contextual instructions. Future studies should investigate the neuro-anatomical basis of this deficit.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2014.09.017DOI Listing

Publication Analysis

Top Keywords

major depression
8
general slowing
8
speed accuracy
8
depression
7
modulating speed-accuracy
4
speed-accuracy strategies
4
strategies major
4
depression background
4
background depression
4
depression associated
4

Similar Publications

Is there a mental health diagnostic crisis in primary care? Current research practices in global mental health cannot answer that question.

Epidemiol Psychiatr Sci

January 2025

Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, Center for Global Mental Health, King's College London, London, UK.

In low- and middle-income countries, fewer than 1 in 10 people with mental health conditions are estimated to be accurately diagnosed in primary care. This is despite more than 90 countries providing mental health training for primary healthcare workers in the past two decades. The lack of accurate diagnoses is a major bottleneck to reducing the global mental health treatment gap.

View Article and Find Full Text PDF

Effects of psilocybin on mouse brain microstructure.

AJNR Am J Neuroradiol

January 2025

From the Department of Radiology (P.C.F., A.P.S., J.J.Y.).

Background And Purpose: There is surging interest in the therapeutic potential of psychedelic compounds like psilocybin in the treatment of psychiatric illnesses like major depressive disorder (MDD). Recent studies point to the rapid antidepressant effect of psilocybin; however, the biological mechanisms underlying these differences remain unknown. This study determines the feasibility of using diffusion MRI to characterize and define the potential spatiotemporal microstructural differences in the brain following psilocybin treatment in C57BL/6J male mice.

View Article and Find Full Text PDF

Mental Well-being in Menopause.

Obstet Gynecol Clin North Am

March 2025

Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address:

The hormonal changes that accompany the transition to menopause are disruptive to most women, and for some, mental health maybe adversely affected. Depressive symptoms and major depression are the best-studied conditions in association with menopause, but anxiety, executive function, and comorbid pre-existing psychiatric conditions all influence the symptomatology that women will experience during this phase of their lives. The epidemiology, diagnosis, and evidence-based treatment guidelines for perimenopausal patients are discussed.

View Article and Find Full Text PDF

This is a review of the existing literature and guidelines for the screening, management, and follow-up of perinatal mood and anxiety disorders, with a focus on major depressive disorder and generalized anxiety disorder.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!